# COMBIVIR

NDC: 49702-202
Generic name: lamivudine and zidovudine
Labeler / Manufacturer: ViiV Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20101019
Marketing ended: 20270228
FDA application: NDA020857

## Active ingredients

- LAMIVUDINE: 150 mg/1
- ZIDOVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49702-202"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49702-202
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16da660b-9981-4d24-a14a-94c7744fce4f